"Maintaining HIV and HCV prevention and care for people who inject drugs despite COVID-19 in Hai Phong, Vietnam".


Journal

The International journal on drug policy
ISSN: 1873-4758
Titre abrégé: Int J Drug Policy
Pays: Netherlands
ID NLM: 9014759

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 20 04 2022
revised: 31 08 2022
accepted: 15 09 2022
pubmed: 17 10 2022
medline: 15 12 2022
entrez: 16 10 2022
Statut: ppublish

Résumé

After the emergence of COVID-19, a one-month strict lockdown was imposed in April 2020 in Vietnam, followed by lighter social distancing restrictions over the year. We investigated whether those measures affected people who inject drugs (PWID) in terms of risk behaviors for HIV and HCV and access to prevention and care in the city of Haiphong, a historic hotspot for HIV and drug use. We carried out a 'before-after' study from 2019 to 2020 using respondent-driven sampling method to enroll PWID. They were interviewed on their socioeconomic situation, drug use and sexual behaviors, relations to care services and tested for drugs and methadone in the urine, for HIV, HCV, and HIV plasma viral load when HIV-positive. Changes following the restrictions were assessed by comparing 'before' to 'after' data. 780 PWID were enrolled. Mean age was 44 years; 94% were male. All were actively injecting heroin 'before', versus 56% 'after'. Among those, frequency of consumption decreased from 24 to 17 days per month. No changes were observed in the frequency and practices of methamphetamine smoking. The proportion of PWID on MMT increased from 68.7% to 75.3%, and that of PWID engaging in risky behaviors related to drug injection decreased from 6.0% to 1.5%. No HIV seroconversions were observed; HCV incidence was 2.6/100 person-years (95% CI [0.7-6.7]). 9% of PWID reported a monthly income of less than 130USD 'before' versus 53% 'after'. The case of Hai Phong shows that it is possible, during times of COVID-19 pandemic, to maintain access to harm reduction and care and to prevent HIV and HCV transmission among PWID in a resource-limited setting where severe social distancing restrictions are implemented. Further research is needed to assess the consequences of long-term economic difficulties and the impact of actual spread of SARS-Cov2 that has since emerged in Haiphong.

Sections du résumé

BACKGROUND BACKGROUND
After the emergence of COVID-19, a one-month strict lockdown was imposed in April 2020 in Vietnam, followed by lighter social distancing restrictions over the year. We investigated whether those measures affected people who inject drugs (PWID) in terms of risk behaviors for HIV and HCV and access to prevention and care in the city of Haiphong, a historic hotspot for HIV and drug use.
METHODOLOGY METHODS
We carried out a 'before-after' study from 2019 to 2020 using respondent-driven sampling method to enroll PWID. They were interviewed on their socioeconomic situation, drug use and sexual behaviors, relations to care services and tested for drugs and methadone in the urine, for HIV, HCV, and HIV plasma viral load when HIV-positive. Changes following the restrictions were assessed by comparing 'before' to 'after' data.
RESULTS RESULTS
780 PWID were enrolled. Mean age was 44 years; 94% were male. All were actively injecting heroin 'before', versus 56% 'after'. Among those, frequency of consumption decreased from 24 to 17 days per month. No changes were observed in the frequency and practices of methamphetamine smoking. The proportion of PWID on MMT increased from 68.7% to 75.3%, and that of PWID engaging in risky behaviors related to drug injection decreased from 6.0% to 1.5%. No HIV seroconversions were observed; HCV incidence was 2.6/100 person-years (95% CI [0.7-6.7]). 9% of PWID reported a monthly income of less than 130USD 'before' versus 53% 'after'.
CONCLUSION CONCLUSIONS
The case of Hai Phong shows that it is possible, during times of COVID-19 pandemic, to maintain access to harm reduction and care and to prevent HIV and HCV transmission among PWID in a resource-limited setting where severe social distancing restrictions are implemented. Further research is needed to assess the consequences of long-term economic difficulties and the impact of actual spread of SARS-Cov2 that has since emerged in Haiphong.

Identifiants

pubmed: 36244242
pii: S0955-3959(22)00286-9
doi: 10.1016/j.drugpo.2022.103870
pmc: PMC9489978
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103870

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declarations of Interest The authors declare that there are no conflicts of interest regarding the publication of this paper.

Références

Int J Drug Policy. 2016 Jun;32:50-6
pubmed: 27006257
AIDS. 2020 Dec 1;34(15):2305-2311
pubmed: 33048884
Harm Reduct J. 2021 May 10;18(1):52
pubmed: 33971892
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211031760
pubmed: 34235993
Lancet Reg Health West Pac. 2021 Dec 13;18:100337
pubmed: 35024661
Drug Alcohol Depend. 2018 Apr 01;185:106-111
pubmed: 29432973
AIDS Care. 2016 Oct;28(10):1312-5
pubmed: 27178119
AIDS. 2020 Nov 1;34(13):1875-1882
pubmed: 32910061
West J Emerg Med. 2020 Aug 18;21(5):1102-1104
pubmed: 32970561
Harm Reduct J. 2022 Jan 29;19(1):6
pubmed: 35090482
Ann Intern Med. 2020 Jul 7;173(1):61-62
pubmed: 32240293
J Clin Epidemiol. 2021 Nov;139:38-48
pubmed: 34280476
Asia Pac J Public Health. 2020 Nov;32(8):469-470
pubmed: 32909472
PLoS One. 2021 Nov 18;16(11):e0259983
pubmed: 34793523
N Engl J Med. 2020 Feb 27;382(9):872-874
pubmed: 31991079
Sex Transm Dis. 2020 Jan;47(1):1-3
pubmed: 31517770
BMC Public Health. 2015 Jan 29;15:32
pubmed: 25631330
J Subst Abuse Treat. 2021 Jul;126:108320
pubmed: 34116818
J Community Health. 2021 Oct;46(5):960-966
pubmed: 33770334
Drug Alcohol Depend. 2021 Apr 1;221:108584
pubmed: 33607497
AIDS Behav. 2021 Feb;25(2):311-321
pubmed: 32654021
Int J Drug Policy. 2020 Sep;83:102958
pubmed: 33183679
Sci Rep. 2020 Apr 24;10(1):6999
pubmed: 32332986
AIDS Behav. 2021 May;25(5):1323-1330
pubmed: 33389320
AIDS Behav. 2018 Jul;22(7):2161-2171
pubmed: 28612212

Auteurs

Hoang Thi Giang (HT)

Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam. Electronic address: htgiang@hpmu.edu.vn.

Nguyen Quang Duc (NQ)

Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.

Jean-Pierre Molès (JP)

Pathogenesis and Control of Chronic & Emerging Infections, University of Montpellier, INSERM, Établissement Français du Sang, University of Antilles-Guyane, Montpellier, France.

Vu Hai Vinh (VH)

Infectious and Tropical Diseases Department, Viet Tiep Hospital, Hai Phong, Vietnam.

Nicolas Nagot (N)

Pathogenesis and Control of Chronic & Emerging Infections, University of Montpellier, INSERM, Établissement Français du Sang, University of Antilles-Guyane, Montpellier, France.

Nham Thi Tuyet Thanh (NTT)

Supporting Community Development Initiatives, Hanoi, Vietnam.

Duong Thi Huong (DT)

Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.

Khuat Thi Hai Oanh (KTH)

Supporting Community Development Initiatives, Hanoi, Vietnam.

Pham Minh Khue (PM)

Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.

Le Sao Mai (LS)

Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.

Nguyen Thu Trang (NT)

Hanoi Medical University, Hanoi, Vietnam.

Pham Thi Ngoc (PT)

Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.

Catherine Quillet (C)

Pathogenesis and Control of Chronic & Emerging Infections, University of Montpellier, INSERM, Établissement Français du Sang, University of Antilles-Guyane, Montpellier, France.

Jonathan Feelemyer (J)

New York University School of Global Public Health, New York, USA.

Roselyne Vallo (R)

Pathogenesis and Control of Chronic & Emerging Infections, University of Montpellier, INSERM, Établissement Français du Sang, University of Antilles-Guyane, Montpellier, France.

Laurent Michel (L)

CESP Inserm UMRS 1018, Paris Saclay University, Pierre Nicole Center, French Red Cross, Paris, France.

Don Des Jarlais (DD)

New York University School of Global Public Health, New York, USA.

Didier Laureillard (D)

Infectious Diseases Department, Caremeau University Hospital, Nimes, France.

Delphine Rapoud (D)

Pathogenesis and Control of Chronic & Emerging Infections, University of Montpellier, INSERM, Établissement Français du Sang, University of Antilles-Guyane, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH